Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $51.2 million.

  • MDxHealth's Total Current Liabilities rose 1233.83% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.2 million, marking a year-over-year increase of 1233.83%. This contributed to the annual value of $42.7 million for FY2024, which is 11852.69% up from last year.
  • As of Q3 2025, MDxHealth's Total Current Liabilities stood at $51.2 million, which was up 1233.83% from $41.2 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Total Current Liabilities registered a high of $51.2 million during Q3 2025, and its lowest value of $16.4 million during Q4 2021.
  • For the 5-year period, MDxHealth's Total Current Liabilities averaged around $31.6 million, with its median value being $31.1 million (2022).
  • In the last 5 years, MDxHealth's Total Current Liabilities surged by 14160.96% in 2024 and then crashed by 846.0% in 2025.
  • Over the past 5 years, MDxHealth's Total Current Liabilities (Quarter) stood at $16.4 million in 2021, then increased by 11.23% to $18.3 million in 2022, then rose by 6.81% to $19.5 million in 2023, then skyrocketed by 118.53% to $42.7 million in 2024, then increased by 19.92% to $51.2 million in 2025.
  • Its Total Current Liabilities was $51.2 million in Q3 2025, compared to $41.2 million in Q2 2025 and $43.2 million in Q1 2025.